MolNFT v2 · #159021 · protein
Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and antibodies VRC03 and PGT122
6NF2: “Cryo-EM structure of vaccine-elicited antibody 0PV-c.01 in complex with HIV-1 Env BG505 DS-SOSIP and…”. Electron microscopy at 3.7, 3 ligands (NAG, MAN, BMA). MolNFT v2 #159021 on GenesisL1: 3D structure, binding sites and pockets…
- PDB
- 6NF2
- Type
- protein
- Length
- 3,867 residues
- Chains
- 24
- Method
- electron microscopy
- Collection
- MolNFT v2 / PDB Bank
- Contract
- 0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
- Owner
- 0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
- Resolution
- 3.7
- Source
- Homo sapiens; Human immunodeficiency virus 1
- UniProt
- Q2N0S6
- Ligands
- NAG, MAN, BMA
Structure
electron microscopy · resolution 3.7 · 8 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A, G, Q | — | protein | 453 | — | Q2N0S6 |
| B, I, R | — | protein | 132 | — | Q2N0S6 |
| C, N, V | — | protein | 128 | — | — |
| D, M, U | — | protein | 102 | — | — |
| E, J, S | — | protein | 132 | — | — |
| F, K, T | — | protein | 105 | — | — |
| H, O, W | — | protein | 125 | — | — |
| L, P, X | — | protein | 112 | — | — |
Ligands and binding sites
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 105 copies · chains A, J, K, N, M, G, F, E, C, D, Q, T, S, V, U, B, I, R
- MAN · alpha-D-mannopyranose · sugar · 48 copies · chains J, K, N, A, M, E, F, C, G, D, S, T, V, Q, U
- BMA · beta-D-mannopyranose · sugar · 33 copies · chains J, A, N, E, G, C, S, Q, V
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q2N0S6
- Elsewhere: RCSB PDB 6NF2 · PDBe 6NF2 · UniProt Q2N0S6
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.